Mucopolysaccharidosis Type II—An Unexpected “3 in 1” Family

Pediatrics and Neonatology - Singapore
doi 10.1016/j.pedneo.2015.11.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mucopolysaccharidosis Type 1

2020English

Mucopolysaccharidosis Type II: Enzyme Replacement Therapy Efficiency

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2020English

Dentinogenesis Imperfecta Type II: An Affected Family Saga

Journal of oral science
MedicineDentistry
2007English

Mucopolysaccharidosis Type 7

2020English

Pharmacoeconomic Evaluation of Drugs Used in Enzyme Replacement Therapy Mucopolysaccharidosis Type II

Pharmacoeconomics: theory and practice
2019English

Publisher Correction: Fast, Sensitive Method for Trisaccharide Biomarker Detection in Mucopolysaccharidosis Type 1

Scientific Reports
Multidisciplinary
2018English

Treatment of Mucopolysaccharidosis Type II (Hunter Syndrome): Results From a Systematic Evidence Review

Genetics in Medicine
MedicineGenetics
2017English

Crystallographic Identification of an Unexpected By-Product in an Ullman's Reaction Toward Biphenyls: 1-(4-Hexyloxy-3-Hydroxyphenyl)ethanone

Acta crystallographica. Section C, Structural chemistry
Condensed Matter PhysicsTheoretical ChemistryInorganic ChemistryMaterials ChemistryMedicinePhysical
2015English

Prenatal Mucopolysaccharidosis II (Hunter): A Pathogenetic Study

Pediatric Research
Child HealthPediatricsPerinatology
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy